Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

299
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
299
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

261
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
261
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

415
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
415
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview01:25

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

270
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
270
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

471
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
471
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

205
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational identification of human ubiquitination sites using convolutional and recurrent neural networks.

Molecular omics·2021
Same author

Prediction of zinc-binding sites using multiple sequence profiles and machine learning methods.

Molecular omics·2019
Same author

Effects of simvastatin on the function of splenic CD4<sup>+</sup> and CD8<sup>+</sup> T cells in sepsis mice.

Immunologic research·2018
Same author

Observation of photoassociation of ultracold sodium and cesium at the asymptote Na (3S<sub>1/2</sub>) + Cs (6P<sub>1/2</sub>).

The Journal of chemical physics·2018
Same author

A Secure Alignment Algorithm for Mapping Short Reads to Human Genome.

Journal of computational biology : a journal of computational molecular cell biology·2018
Same author

Effect of Source/Drain Electrodes on the Electrical Properties of Silicon⁻Tin Oxide Thin-Film Transistors.

Nanomaterials (Basel, Switzerland)·2018
Same journal

Enhancing electrical and thermoelectrical performance of graphene nanoribbons through geometrical defect engineering.

Journal of molecular modeling·2026
Same journal

15-Crown-5-based metalides: computational insights into excess electrons and enhanced NLO response.

Journal of molecular modeling·2026
Same journal

A DFT study on the structures, properties, and interfacial interactions of cage-like HMX@cyclo[n]carbons energetic composites.

Journal of molecular modeling·2026
Same journal

Polarity‑controlled Lewis acid catalysis in the Diels-Alder reaction of cyclopentadiene and acrolein: a DFT and global electron density transfer (GEDT) analysis of BF<sub>3</sub> and AlCl<sub>3</sub>.

Journal of molecular modeling·2026
Same journal

The feasibility and analysis of 2D bilayer SiC as an alcohol sensor: a first-principle study.

Journal of molecular modeling·2026
Same journal

Dynamic molecular simulation for CL-20/3,5-MDNP(1-methyl-3,5-dinitropyrazole) co-crystal PBX explosives.

Journal of molecular modeling·2026
See all related articles

Related Experiment Video

Updated: Dec 28, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

DDAPRED: a computational method for predicting drug repositioning using regularized logistic matrix factorization.

Xiaofeng Wang1, Renxiang Yan2,3

  • 1College of Mathematics and Computer Science, Shanxi Normal University, Linfen, 041004, China.

Journal of Molecular Modeling
|February 17, 2020
PubMed
Summary
This summary is machine-generated.

Drug repositioning accelerates new drug indications by analyzing existing drugs. A new computational method, DDAPRED, improves prediction accuracy, outperforming existing approaches for drug discovery.

Keywords:
Drug repositioningDrug-disease associationLogistic matrix factorizationPrediction

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.5K

Related Experiment Videos

Last Updated: Dec 28, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.5K

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • Traditional drug discovery faces high costs and slow output.
  • Drug repositioning offers a promising alternative by finding new uses for existing drugs.
  • Computational methods can further enhance drug repositioning efficiency and accuracy.

Purpose of the Study:

  • To propose a novel computational method, DDAPRED, for improving drug repositioning prediction.
  • To integrate diverse drug and disease similarity data for enhanced prediction.
  • To validate the performance and practicability of the proposed DDAPRED method.

Main Methods:

  • Developed DDAPRED, a computational method for drug repositioning prediction.
  • Integrated multiple sources of drug similarity and disease similarity information.
  • Employed regularized logistic matrix decomposition for performance enhancement.

Main Results:

  • DDAPRED achieved an Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.932 and an Area Under the Precision-Recall Curve (AUPRC) of 0.438 in 5-fold cross-validation.
  • The method demonstrated superior performance compared to existing drug repositioning prediction approaches.
  • Analysis confirmed the practicability of DDAPRED through verification of top predictions.

Conclusions:

  • DDAPRED significantly improves drug repositioning prediction accuracy.
  • The integration of multiple similarity sources and advanced decomposition methods is key to its success.
  • DDAPRED offers a practical and effective tool for accelerating drug discovery and development.